| dc.description.abstract | The purpose of this thesis is to provide insight into the complexities of the pharmaceutical industry
and the subsequent role that patent protection influences both consumer markets and business
operations. The methods used are a combination of detailed market research, case studies and a
comprehensive analysis of fifteen industry leaders. The sector is heavily reliant on exceedingly
high research and development expenditures which exemplifies the incessant need for an adequate
patent system. The market is dominated by few, large multinational corporations and their patented
brand name drugs. The results show that the current environment has led to several imbalances in
the global pharmaceutical market. The predominant issues in the industry are limited access to
affordable drugs, monopolistic market power created by extensive exclusivity periods, and skewed
incentives that impact firm decision-making. The current system does not address traditional
market forces that are inherent to private firms and subsequently influence research investments
focused on Western markets. This has important implications on both developing nations and
overall global health standards. | nb_NO |
